NCT01619878 - Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Acute Uncomplicated Falciparum Malaria

Interventions

DRUG

Artemether-lumefantrine (COA566)

One dispersible tablet taken orally twice a day during 3 days.

Trial Locations (7)

Novartis Investigative Site, Burkina Faso

Novartis Investigative Site, Cotonou

Novartis investigative site, Cotonou

Novartis investigative site, Ouagadougou

Novartis investigative site, Calabar

Novartis investigative site, Kinshasa

Novartis investigative site, Lomé